Impaired hypoxic pulmonary vasoconstriction in a mouse model of Leigh syndrome

Hypoxic pulmonary vasoconstriction (HPV) is a physiological vasomotor response that maintains systemic oxygenation by matching perfusion to ventilation during alveolar hypoxia. Although mitochondria appear to play an essential role in HPV, the impact of mitochondrial dysfunction on HPV remains incompletely defined. Mice lacking the mitochondrial complex I (CI) subunit Ndufs4 (Ndufs4−/−) develop a fatal progressive encephalopathy and serve as a model for Leigh syndrome, the most common mitochondrial disease in children. Breathing normobaric 11% O2 prevents neurological disease and improves survival in Ndufs4−/− mice. In this study, we found that either genetic Ndufs4 deficiency or pharmacological inhibition of CI using piericidin A impaired the ability of left mainstem bronchus occlusion (LMBO) to induce HPV. In mice breathing air, the partial pressure of arterial oxygen during LMBO was lower in Ndufs4−/− and in piericidin A-treated Ndufs4+/+ mice than in respective controls. Impairment of HPV in Ndufs4−/− mice was not a result of nonspecific dysfunction of the pulmonary vascular contractile apparatus or pulmonary inflammation. In Ndufs4-deficient mice, 3 wk of breathing 11% O2 restored HPV in response to LMBO. When compared with Ndufs4−/− mice breathing air, chronic hypoxia improved systemic oxygenation during LMBO. The results of this study show that, when breathing air, mice with a congenital Ndufs4 deficiency or chemically inhibited CI function have impaired HPV. Our study raises the possibility that patients with inborn errors of mitochondrial function may also have defects in HPV.

[1]  V. Mootha,et al.  Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome , 2017, Proceedings of the National Academy of Sciences.

[2]  D. Panigrahy,et al.  Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[3]  D. Goodlett,et al.  Normalization of NAD+ Redox Balance as a Therapy for Heart Failure , 2016, Circulation.

[4]  W. Fenical,et al.  The unique chemistry and biology of the piericidins , 2016, The Journal of Antibiotics.

[5]  Neville E. Sanjana,et al.  Hypoxia as a therapy for mitochondrial disease , 2016, Science.

[6]  P. Slinger,et al.  Hypoxic Pulmonary Vasoconstriction: Physiology and Anesthetic Implications , 2015, Anesthesiology.

[7]  L. de Meirleir,et al.  A multicenter study on Leigh syndrome: disease course and predictors of survival , 2014, Orphanet Journal of Rare Diseases.

[8]  Edward T Chouchani,et al.  Complex I Deficiency Due to Selective Loss of Ndufs4 in the Mouse Heart Results in Severe Hypertrophic Cardiomyopathy , 2014, PloS one.

[9]  Matt Kaeberlein,et al.  mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome , 2013, Science.

[10]  Naifang Lu,et al.  Deletion of the Murine Cytochrome P450 Cyp2j Locus by Fused BAC-Mediated Recombination Identifies a Role for Cyp2j in the Pulmonary Vascular Response to Hypoxia , 2013, PLoS genetics.

[11]  J. Smeitink,et al.  Primary fibroblasts of NDUFS4(-/-) mice display increased ROS levels and aberrant mitochondrial morphology. , 2013, Mitochondrion.

[12]  Wang Wang,et al.  Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure. , 2013, Cell metabolism.

[13]  J. Hirst Mitochondrial complex I. , 2013, Annual review of biochemistry.

[14]  W. Zapol,et al.  Hemoglobin infusion does not alter murine pulmonary vascular tone. , 2013, Nitric oxide : biology and chemistry.

[15]  Vamsi K. Mootha,et al.  Mitochondrial disorders as windows into an ancient organelle , 2012, Nature.

[16]  R. Palmiter,et al.  Fatal breathing dysfunction in a mouse model of Leigh syndrome. , 2012, The Journal of clinical investigation.

[17]  M. Tarnopolsky,et al.  Natural disease course and genotype-phenotype correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 cases , 2012, Journal of Inherited Metabolic Disease.

[18]  K. Austen,et al.  Cysteinyl Leukotrienes Impair Hypoxic Pulmonary Vasoconstriction in Endotoxemic Mice , 2011, Anesthesiology.

[19]  R. Palmiter,et al.  Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome , 2010, Proceedings of the National Academy of Sciences.

[20]  W. Watt,et al.  Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. , 2008, Cell metabolism.

[21]  A. Bagchi,et al.  Activation of Toll-like receptor 2 impairs hypoxic pulmonary vasoconstriction in mice. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[22]  J. Smeitink,et al.  Superoxide production is inversely related to complex I activity in inherited complex I deficiency. , 2007, Biochimica et biophysica acta.

[23]  O. V. Evgenov,et al.  NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in mice. , 2005, Journal of applied physiology.

[24]  J. Turrens,et al.  Mitochondrial formation of reactive oxygen species , 2003, The Journal of physiology.

[25]  W. Seeger,et al.  Effects of mitochondrial inhibitors and uncouplers on hypoxic vasoconstriction in rabbit lungs. , 2003, American journal of respiratory cell and molecular biology.

[26]  E. Michelakis,et al.  The mechanism(s) of hypoxic pulmonary vasoconstriction: potassium channels, redox O(2) sensors, and controversies. , 2002, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[27]  S. Archer,et al.  Diversity in Mitochondrial Function Explains Differences in Vascular Oxygen Sensing , 2002, Circulation research.

[28]  J. Bonventre,et al.  Cytosolic phospholipase A2 in hypoxic pulmonary vasoconstriction , 2002 .

[29]  J. Bonventre,et al.  Cytosolic phospholipase A(2) in hypoxic pulmonary vasoconstriction. , 2002, The Journal of clinical investigation.

[30]  R. Leach,et al.  Divergent roles of glycolysis and the mitochondrial electron transport chain in hypoxic pulmonary vasoconstriction of the rat: identity of the hypoxic sensor , 2001, The Journal of physiology.

[31]  N. Chandel,et al.  Model for Hypoxic Pulmonary Vasoconstriction Involving Mitochondrial Oxygen Sensing , 2001, Circulation research.

[32]  S. Archer,et al.  Alterations in a redox oxygen sensing mechanism in chronic hypoxia. , 2001, Journal of applied physiology.

[33]  A. Sapirstein,et al.  Attenuation of Hypoxic Pulmonary Vasoconstriction by Endotoxemia Requires 5-Lipoxygenase in Mice , 2001, Circulation research.

[34]  T. Henry,et al.  A redox-based O2 sensor in rat pulmonary vasculature. , 1993, Circulation research.

[35]  K. Kubo,et al.  [Hypoxic pulmonary vasoconstriction]. , 1985, Kokyu to junkan. Respiration & circulation.

[36]  M. K. Sykes,et al.  The relationship between hypoxic pulmonary vasoconstriction and arterial oxygen tension in the intact dog. , 1983, The Journal of physiology.

[37]  J. W. Shaw,et al.  Effect of changes in blood pH on the vascular resistance of the normal and hypoxic cat lung. , 1971, Cardiovascular research.

[38]  F. L. Crane,et al.  Piericidin A: a new inhibitor of mitochondrial electron transport. , 1966, Biochemical and biophysical research communications.

[39]  Hoon-Chul Kang,et al.  Cause of Death in Children With Mitochondrial Diseases. , 2017, Pediatric neurology.

[40]  R. Palmiter,et al.  Mitochondrial complex III stabilizes complex I in the absence of NDUFS4 to provide partial activity. , 2012, Human molecular genetics.

[41]  P. Kruhøffer Determination of Inulin in Urine and Plasma , 1946 .